None listed
Conditions
Brief summary
The aim of the study is to measure the amount of folate-binding protein in human milk and to determine if it is down-regulated by high folic acid consumption using maternal blood folic acid and total folate status as biomarkers.
Interventions
The primary exposure of interest is the blood folic acid concentration and blood folate status of the mother. The study aims to observe the effect of maternal blood folate status on milk folate-binding protein concentration and on infant blood folate status. Blood folic acid status and blood total folate status of the mother are assessed at 8 weeks postpartum (the folate status of the mother will be conditional on the previous folate and folic acid intake, most likely over the course of the pregnancy as steady state concentrations are only reached after 40 or more weeks). Folate-binding protein concentration and total folate in breast-milk at 8 weeks postpartum is also measured as an exposure variable in relation to infant folate status.
Sponsors
Eligibility
Inclusion criteria
Maternal age 18 to 42 years Healthy singleton infant born between 37 to 42 weeks gestation inclusive Exclusive breastfeeding
Exclusion criteria
High risk pregnancy (eclampsia or HELLP syndrome) Diabetes Cardiac disease Renal disease Inflammatory bowel syndrome Coeliac Disease Gastric bypass surgery Medications (valproic acid, carbamazepine, phenobarbital, primidone, methotrexate, fluorouracil, premetrexed, pyrimethamine, trimethoprim, thiazide diuretics, sulfasalazine, pancreatin, cholestryramine, colestipol, metformin)